A multicenter, randomized, parallel-group confirmatory study protocol to evaluate the efficacy of Soft Protector CPC, a novel oral mucosal protectant, in preventing oral mucositis and alleviating pain in patients with breast cancer

Kazuhiro Omori, Kohei Furukawa, Masatoshi Usubuchi, Tomofumi Hamada, Tadahiko Shien, Michihiro Yoshida, Yuki Nakatsuka, Katsuyuki Hotta · 2026

Read A multicenter, randomized, parallel-group confirmatory study protocol to evaluate the efficacy of Soft Protector CPC, a novel oral mucosal protectant, in preventing oral mucositis and alleviating pain in patients with breast cancer by Kazuhiro Omori, Kohei Furukawa, Masatoshi Usubuchi, Tomofumi Hamada, Tadahiko Shien, Michihiro Yoshida, Yuki Nakatsuka, Katsuyuki Hotta (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0350803.txt.

Description

Kazuhiro Omori and colleagues in Japan published a trial plan in 2026 for preventing sore mouth during breast cancer chemotherapy. Mouth sores are common, painful, and hard to prevent, and creams wear off fast and ignore rubbing from teeth. No results are reported yet.

About one hundred fifty patients will be split at random between usual mouth care and care plus a soft mouth protector made to shield the lining. Sore severity, pain, and quality of life will be tracked through treatment. A simple shield that works could spare many patients one of chemotherapy's most miserable side effects.

Catalog record

CREATORKazuhiro Omori, Kohei Furukawa, Masatoshi Usubuchi, Tomofumi Hamada, Tadahiko Shien, Michihiro Yoshida, Yuki Nakatsuka, Katsuyuki Hotta
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28852
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0350803

Browse the full library · About the Tower of Babel